.. Appareil-d-"-analyse, 84 b) Maintenance quotidienne, p.86

A. Objectifs and .. , 102 B. Sélection des échantillons et appareil de mesure, p.102

S. Struski, Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities, Leukemia, vol.95, issue.3, pp.617-619, 2008.
DOI : 10.1182/blood-2005-05-2093

S. Struski, ??tude cytologique, immunoph??notypique et??cytog??n??tique d'une??s??rie de??136??cas cons??cutifs d'h??mopathies lympho??des chroniques ????cellules B matures, Pathologie Biologie, vol.55, issue.1, pp.59-72, 2007.
DOI : 10.1016/j.patbio.2006.04.006

L. Miguet, Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis, Blood, vol.124, pp.5407-5407, 2014.

R. Küppers, Mechanisms of B-cell lymphoma pathogenesis, Nature Reviews Cancer, vol.2, issue.4, pp.251-262, 2005.
DOI : 10.1038/nrc746

G. Lenz and L. M. Staudt, Aggressive Lymphomas, New England Journal of Medicine, vol.362, issue.15, pp.1417-1429, 2010.
DOI : 10.1056/NEJMra0807082

H. Swerdlow, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008.

C. Nabhan and S. T. Rosen, Chronic Lymphocytic Leukemia, JAMA, vol.312, issue.21, pp.2265-2276, 2014.
DOI : 10.1001/jama.2014.14553

L. Baseggio and P. Felman, Diagnostic des lymphocytoses hors LLC-typique, Revue Francophone des Laboratoires, vol.2013, issue.452, pp.93-102, 2013.
DOI : 10.1016/S1773-035X(13)72036-7

V. Eclache and F. Baran-marszak, Int??r??t de la cytog??n??tique et de la biologie mol??culaire pour le diagnostic des syndromes lymphoprolif??ratifs B, Revue Francophone des Laboratoires, vol.2013, issue.452, pp.49-59, 2013.
DOI : 10.1016/S1773-035X(13)72032-X

F. Cymbalist, LLC: physiopathologie, diagnostic et approche th??rapeutique, Revue Francophone des Laboratoires, vol.2013, issue.452, pp.61-71, 2013.
DOI : 10.1016/S1773-035X(13)72033-1

L. Gouill and S. , Le lymphome ?? cellules du manteau??: du diagnostic aux perspectives th??rapeutiques, La Revue de M??decine Interne, vol.31, issue.9, pp.615-620, 2010.
DOI : 10.1016/j.revmed.2009.05.016

G. Sébahoun, Cahier de Formation BIOFORMA : Les lymphomes, 2010.

L. Zhang, Polyclonal Antibody Targeting SOX11 Cannot Differentiate Mantle Cell Lymphoma From B-Cell Non-Hodgkin Lymphomas, American Journal of Clinical Pathology, vol.70, issue.6, pp.795-800, 2013.
DOI : 10.1158/0008-5472.CAN-09-3419

C. Sarkozy, Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index, Genes, Chromosomes and Cancer, vol.84, issue.1, pp.106-116, 2014.
DOI : 10.1111/j.1365-2141.2008.07329.x

A. Traverse-glehen, Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity, Discov. Med, vol.13, pp.253-265, 2012.

E. Matutes, Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria, Leukemia, vol.90, issue.3, pp.487-495, 2007.
DOI : 10.1002/hep.1840360702

X. Troussard, A. Belmekki, M. Malet, and E. Cornet, ??tude des h??mopathies malignes avec cellules chevelues, Revue Francophone des Laboratoires, vol.2013, issue.452, pp.83-91, 2013.
DOI : 10.1016/S1773-035X(13)72035-5

E. Cornet, Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia, Annals of Hematology, vol.107, issue.12, pp.1977-1983, 2014.
DOI : 10.1182/blood-2005-11-4590

URL : https://hal.archives-ouvertes.fr/hal-01699263

R. Kridel, L. H. Sehn, and R. D. Gascoyne, Pathogenesis of follicular lymphoma, Journal of Clinical Investigation, vol.122, issue.10
DOI : 10.1172/JCI63186

M. Dungarwalla, E. Matutes, and C. Dearden, Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper, European Journal of Haematology, vol.106, issue.2 Suppl 5, pp.469-476, 2008.
DOI : 10.1200/JCO.20.1.205

. Nguyen-khac, La leucémie prolymphocytaire B. Horiz, 2014.

M. L. Mcmaster, Long-term Evaluation of Three Multiple-Case Waldenstrom Macroglobulinemia Families, Clinical Cancer Research, vol.13, issue.17, pp.5063-5069, 2007.
DOI : 10.1158/1078-0432.CCR-07-0299

R. M. De-tute, Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies, Histopathology, vol.129, issue.Suppl. 1, pp.90-105, 2011.
DOI : 10.1309/05GFG3LY3VYCDMEY

URL : https://hal.archives-ouvertes.fr/hal-00613813

H. Jouault and M. Imbert, La cytom??trie en flux: int??r??t et applications en h??matologie, Revue Fran??aise des Laboratoires, vol.1995, issue.275
DOI : 10.1016/S0338-9898(95)80058-1

H. Merle-béral and M. Le-garff-tavernier, Immunoph??notypage des h??mopathies malignes par cytom??trie de flux, EMC - H??matologie, vol.3, issue.3, pp.1-12, 2008.
DOI : 10.1016/S1155-1984(08)47155-8

M. Roederer, Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats, Cytometry, vol.33, issue.3, pp.194-205, 2001.
DOI : 10.1002/(SICI)1097-0320(19981001)33:2<256::AID-CYTO22>3.0.CO;2-S

URL : http://onlinelibrary.wiley.com/doi/10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C/pdf

M. Roederer, 8 Color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity, Cytometry, vol.29, issue.4, pp.328-339, 1997.
DOI : 10.1002/(SICI)1097-0320(19971201)29:4<328::AID-CYTO10>3.0.CO;2-W

L. Garff-tavernier, Immunophénotypage lymphocytaire dans les syndromes lymphoprolifératifs chroniques, 2013.

F. Craig, Flow Cytometric Evaluation of B-cell Lymphoid Neoplasms, Clinics in Laboratory Medicine, vol.27, issue.3
DOI : 10.1016/j.cll.2007.05.003

M. C. Béné, Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10, Leukemia, vol.75, issue.4, pp.567-574, 2011.
DOI : 10.1080/15476910802129661

F. E. Craig and K. A. Foon, Flow cytometric immunophenotyping for hematologic neoplasms, Blood, vol.111, issue.8, pp.3941-3967, 2008.
DOI : 10.1182/blood-2007-11-120535

URL : http://www.bloodjournal.org/content/bloodjournal/111/8/3941.full.pdf

B. L. Wood, Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia, 2006.

E. Matutes, The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL, Leukemia, vol.8, pp.1640-1645, 1994.

E. J. Moreau, Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b), American Journal of Clinical Pathology, vol.108, issue.4, pp.378-382, 1997.
DOI : 10.1093/ajcp/108.4.378

E. Matutes, A. Attygalle, A. Wotherspoon, and D. Catovsky, Diagnostic issues in chronic lymphocytic leukaemia (CLL), Best Practice & Research Clinical Haematology, vol.23, issue.1, pp.3-20, 2010.
DOI : 10.1016/j.beha.2010.01.001

M. L. Garff-tavernier, M. Costopoulos, and H. Merle-béral, Place de la cytom??trie en flux dans le diagnostic et le suivi des syndromes lymphoprolif??ratifs B, Revue Francophone des Laboratoires, vol.2013, issue.452, pp.37-48, 2013.
DOI : 10.1016/S1773-035X(13)72031-8

M. Hallek, Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, vol.111, issue.12, pp.5446-5456, 2008.
DOI : 10.1182/blood-2007-06-093906

S. L. Asplund, R. W. Mckenna, J. E. Doolittle, and S. H. Kroft, CD5-Positive B-Cell Neoplasms of Indeterminate Immunophenotype, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.4
DOI : 10.1097/01.pai.0000137363.36091.7e

A. Criel, Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases, British Journal of Haematology, vol.97, issue.2, pp.383-391, 1997.
DOI : 10.1046/j.1365-2141.1997.402686.x

B. Kampalath, M. P. Barcos, and C. Stewart, Phenotypic Heterogeneity of B Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, American Journal of Clinical Pathology, vol.119, issue.6
DOI : 10.1309/4AGUT3LKEURD7T7K

F. Van-bockstaele, B. Verhasselt, and J. Philippé, Prognostic markers in chronic lymphocytic leukemia: A comprehensive review, Blood Reviews, vol.23, issue.1, pp.25-47, 2009.
DOI : 10.1016/j.blre.2008.05.003

M. Sarfati, Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia, Blood, vol.88, pp.4259-4264, 1996.

J. Gao, L. Peterson, B. Nelson, C. Goolsby, and Y. Chen, Immunophenotypic Variations in Mantle Cell Lymphoma, American Journal of Clinical Pathology, vol.132, issue.5, pp.699-706, 2009.
DOI : 10.1309/UQ4N-M5KL-0ANY-YD3G

S. D. Boyd, Y. Natkunam, J. R. Allen, and R. A. Warnke, Selective Immunophenotyping for Diagnosis of B-cell Neoplasms, Applied Immunohistochemistry & Molecular Morphology
DOI : 10.1097/PAI.0b013e31825d550a

M. O. Elnenaei, Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies, Leukemia Research, vol.25, issue.2, pp.115-123, 2001.
DOI : 10.1016/S0145-2126(00)00114-4

H. J. Meyerson, D Cyclins in CD5+ B-Cell Lymphoproliferative Disorders, American Journal of Clinical Pathology, vol.125, issue.2, pp.241-250, 2006.
DOI : 10.1309/7C2VV961P60RMLHD

A. K. Ho, Small B-Cell Neoplasms With Typical Mantle Cell Lymphoma Immunophenotypes Often Include Chronic Lymphocytic Leukemias, American Journal of Clinical Pathology, vol.131, issue.1, pp.27-32, 2009.

L. Baseggio, CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases, Haematologica, vol.95, issue.4, pp.604-612, 2010.
DOI : 10.3324/haematol.2009.011049

URL : https://hal.archives-ouvertes.fr/ensl-00815193

V. H. Velden and . Van-der, B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma, Blood, vol.124, issue.3, pp.412-419, 2014.
DOI : 10.1182/blood-2013-10-533869

C. Hercher, A Multicentric Study of 41 Cases of B-Prolymphocytic Leukemia: Two Evolutive Forms: The Groupe Fran??ais d'H??matologie Cellulaire, Leukemia & Lymphoma, vol.33, issue.1, pp.981-987, 2001.
DOI : 10.3109/10428199909093739

W. G. Morice, Predictive Value of Blood and Bone Marrow Flow Cytometry in B-Cell Lymphoma Classification: Comparative Analysis of Flow Cytometry and Tissue Biopsy in 252 Patients, Mayo Clinic Proceedings, vol.83, issue.7, pp.776-785, 2008.
DOI : 10.4065/83.7.776

E. Matutes, The immunophenotype of hairy cell leukemia (HCL) Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes

H. Shao, Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria, Leukemia Research, vol.37, issue.4, pp.401-409, 2013.
DOI : 10.1016/j.leukres.2012.11.021

D. Giudice and I. , The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes, Haematologica, vol.89, pp.303-308, 2004.

Y. Chen, M. S. Tallman, C. Goolsby, and L. Peterson, Immunophenotypic Variations in Hairy Cell Leukemia, American Journal of Clinical Pathology, vol.125, issue.2, pp.251-259, 2006.
DOI : 10.1309/PMQXVY619Q8Y43AR

URL : https://academic.oup.com/ajcp/article-pdf/125/2/251/4987828/ajcpath125-0251.pdf

H. Y. Dong, J. Weisberger, Z. Liu, and S. Tugulea, Immunophenotypic Analysis of CD103+ B-Lymphoproliferative Disorders, American Journal of Clinical Pathology, vol.131, issue.4
DOI : 10.1002/ajh.10428

G. Kanellis, Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features, Haematologica, vol.95, issue.7, pp.1122-1129, 2010.
DOI : 10.3324/haematol.2009.013714

L. Baseggio, Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL), Hematological Oncology, vol.37, issue.4, pp.47-51, 2011.
DOI : 10.3109/10428190009057637

URL : https://hal.archives-ouvertes.fr/ensl-00808949

P. Lin and L. J. Medeiros, Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia, Advances in Anatomic Pathology, vol.12, issue.5, pp.246-255, 2005.
DOI : 10.1097/01.pap.0000184176.65919.17

G. A. Pangalis, Differential Diagnosis of Waldenstr??m's Macroglobulinemia and Other B-Cell Disorders, Clinical Lymphoma, vol.5, issue.4, pp.235-240, 2005.
DOI : 10.3816/CLM.2005.n.006

Z. R. Hunter, CD5, CD10, and CD23 Expression in Waldenstr??m's Macroglobulinemia, Clinical Lymphoma, vol.5, issue.4, pp.246-249, 2005.
DOI : 10.3816/CLM.2005.n.008

S. Poulain, Macroglobulin??mie de Waldenstr??m, La Revue de M??decine Interne, vol.31, issue.5, pp.385-394, 2010.
DOI : 10.1016/j.revmed.2009.07.016

A. Traverse-glehen, Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?, Blood, vol.111, issue.4, pp.2253-2260, 2008.
DOI : 10.1182/blood-2007-07-098848

R. W. Sharpe and K. J. Bethel, Hairy Cell Leukemia: Diagnostic Pathology, Hematology/Oncology Clinics of North America, vol.20, issue.5
DOI : 10.1016/j.hoc.2006.06.010

M. H. Cessna, L. Hartung, S. Tripp, S. L. Perkins, and D. W. Bahler, Hairy Cell Leukemia Variant, American Journal of Clinical Pathology, vol.21, issue.1, pp.132-138, 2005.

C. H. Dunphy and P. J. Petruska, Atypical prolymphocytic variant of hairy-cell leukemia: Case report and review of the literature, American Journal of Hematology, vol.80, issue.2, pp.121-125, 1996.
DOI : 10.1093/jnci/80.10.765

G. R. Goodman, K. J. Bethel, and A. Saven, Hairy cell leukemia: an update, Current Opinion in Hematology, vol.10, issue.4
DOI : 10.1097/00062752-200307000-00002

E. Matutes, Immunophenotyping and Differential Diagnosis of Hairy Cell Leukemia, Hematology/Oncology Clinics of North America, vol.20, issue.5
DOI : 10.1016/j.hoc.2006.06.012

S. Miguel and J. F. , Immunophenotypic analysis of Waldenstrom's macroglobulinemia, Seminars in Oncology, vol.30, issue.2, pp.187-195, 2003.
DOI : 10.1053/sonc.2003.50074

S. Konoplev, L. J. Medeiros, C. E. Bueso-ramos, J. L. Jorgensen, and P. Lin, Immunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenstr??m Macroglobulinemia, American Journal of Clinical Pathology, vol.124, issue.3, pp.414-420, 2005.
DOI : 10.1309/3G1XDX0DVHBNVKB4

Z. Liu, CD5??? Mantle Cell Lymphoma, American Journal of Clinical Pathology, vol.22, issue.2, pp.216-224, 2002.
DOI : 10.1309/TE56-A43X-29TT-5H8G

URL : https://academic.oup.com/ajcp/article-pdf/118/2/216/4984948/ajcpath118-0216.pdf

E. Matutes, A. Wotherspoon, V. Brito-babapulle, and D. Catovsky, The natural history and clinico-pathological features of the variant form of hairy cell leukemia, Leukemia, vol.15, issue.1, pp.184-186, 2001.
DOI : 10.1038/sj.leu.2401999

P. G. Medd, A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma, Cytometry Part B: Clinical Cytometry, vol.93, issue.4, pp.230-237, 2011.
DOI : 10.1046/j.1365-2141.1996.d01-1711.x

L. Muñoz, Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies, Haematologica, vol.86, pp.1261-1269, 2001.

J. Dürig, CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia, Leukemia, vol.16, issue.1, pp.30-35, 2002.
DOI : 10.1038/sj.leu.2402339

S. Ibrahim, CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia, Blood, vol.98, issue.1, pp.181-186, 2001.
DOI : 10.1182/blood.V98.1.181

A. Visentin, Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia, Clinical Lymphoma Myeloma and Leukemia, vol.15, issue.10
DOI : 10.1016/j.clml.2015.06.001

L. Eisele, T. Haddad, L. Sellmann, U. Dührsen, and J. Dürig, Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia, Leukemia Research, vol.33, issue.6, pp.775-778, 2009.
DOI : 10.1016/j.leukres.2008.09.001

J. Orchard, A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease, Blood, vol.101, issue.>12, pp.4975-4981, 2003.
DOI : 10.1182/blood-2002-06-1864

B. Espinet, Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry, Clinical Cancer Research, vol.20, issue.4, pp.1007-1019, 2014.
DOI : 10.1158/1078-0432.CCR-13-1077

L. Miguet, Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis, J

J. Lesesve, Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms, International Journal of Laboratory Hematology, vol.26, issue.4
DOI : 10.1038/leu.2010.312

URL : https://hal.archives-ouvertes.fr/hal-01668412

C. Serrier, Expression de la molécule CD5 dans une série de patients atteints de Leucémie Lymphoïde Chronique, 2012.

B. Frotscher, J. Lesesve, M. Bene, P. Feugier, and M. De-carvalho-bittencourt, Differential and tumor-specific expression of CD160 and CD200 in chronic B-cell lymphoproliferative disorders, 2012.

M. A. De-la-fuente-garcía, CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes, Blood, vol.91, pp.2800-2809, 1998.

N. Porakishvili, Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes

L. Miguet, Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas, Leukemia, vol.92, issue.8, pp.1748-1750, 2013.
DOI : 10.1084/jem.20120904

S. Tardy, Évaluation des marqueurs CD160 et CD200 pour le diagnostic des syndromes lymphoprolifératifs B chroniques, 2012.

G. A. Palumbo, CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia, Leukemia Research, vol.33, issue.9, pp.1212-1216, 2009.
DOI : 10.1016/j.leukres.2009.01.017

V. Pillai, CD200 Flow Cytometric Assessment and Semiquantitative Immunohistochemical Staining Distinguishes Hairy Cell Leukemia From Hairy Cell Leukemia-Variant and Other B-Cell Lymphoproliferative Disorders, American Journal of Clinical Pathology, vol.140, issue.4, pp.536-543, 2013.

URL : https://academic.oup.com/ajcp/article-pdf/140/4/536/4991973/ajcpath140-0536.pdf

A. F. Sandes, CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry, Cytometry Part B: Clinical Cytometry, vol.86, pp.98-105, 2014.
DOI : 10.1002/cytob.21128

L. Fan, Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis, Leukemia & Lymphoma, vol.2012, issue.12, pp.1-29, 2015.
DOI : 10.1517/14712598.8.1.5

T. Kalina, EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols, Leukemia, vol.70, issue.9, 1986.
DOI : 10.1002/cyto.b.20135

URL : https://hal.archives-ouvertes.fr/hal-00739978

J. J. Van-dongen and A. Orfao, EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine, Leukemia, vol.8, issue.9, pp.1899-1907, 2012.
DOI : 10.1002/ajh.2830400404

P. Poncelet, Microbilles et cytométrie : comment et pourquoi introduire la « ?métrie » dans l " immuno?cytométrie ?, Ann. Biol. Clin. (Paris), vol.62, pp.53-57, 2004.

L. Ginaldi, Levels of expression of CD19 and CD20 in chronic B cell leukaemias, Journal of Clinical Pathology, vol.51, issue.5, pp.364-369, 1998.
DOI : 10.1136/jcp.51.5.364

C. E. Pedreira, Generation of flow cytometry data files with a potentially infinite number of dimensions, Cytometry Part A, vol.242, issue.1, pp.834-846, 2008.
DOI : 10.1002/cyto.b.20140

L. A. Herzenberg, J. Tung, W. A. Moore, L. A. Herzenberg, and D. R. Parks, Interpreting flow cytometry data: a guide for the perplexed, Nature Immunology, vol.45, issue.7, pp.681-685, 2006.
DOI : 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C

P. Challagundla, Utility of Quantitative Flow Cytometry Immunophenotypic Analysis of CD5 Expression in Small B-Cell Neoplasms, Archives of Pathology & Laboratory Medicine, vol.138, issue.7, pp.903-909, 2014.
DOI : 10.5858/arpa.2013-0367-OA